Reosto

Reosto: Patient-Friendly Medicine Guide for Australians

Basic Product Information

Reosto is an herbal formulation promoted for bone health, osteoporosis management, and as supportive therapy for conditions causing bone loss. It is available in oral tablet form and commonly used as part of holistic or complementary health regimes.

Mechanism of Action

In Simple Terms: Reosto combines a selection of natural herbs traditionally used to support bone density, reduce bone loss, and aid in the healing of fractures. Its ingredients—such as Indian bdellium gum and Arjuna bark—are believed to promote healthy bone metabolism, enhance calcium retention, and inhibit bone resorption, thereby supporting overall bone strength.

For Healthcare Specialists: Pre-clinical and limited clinical evidence suggest that Reosto works through antiresorptive activity, modulation of cytokines related to bone turnover, and supporting osteoblastic (bone-building) activity. Compounds such as guggulsterones, present in Indian bdellium, may inhibit osteoclast-mediated bone resorption, while flavonoids and saponins augment osteogenesis. Systematic reviews highlight its efficacy as an adjunct therapy for osteopenia and osteoporosis, but larger, high-quality clinical trials are warranted for conclusive evidence.

Pharmacokinetics

• Absorption: The herbal extracts in Reosto are absorbed through the digestive tract. Exact pharmacokinetic profiles are limited but approximated to herbal matrix behavior: moderate bioavailability with peak plasma levels generally achieved within 1–2 hours after oral administration.
• Metabolism: Primarily hepatic (liver metabolism), involving transformation of plant-derived compounds into metabolites suitable for elimination.
• Elimination: Most metabolites are excreted via the kidneys (urine), with a minor proportion through faeces.
• Duration of Action: As a supportive, cumulative therapy, Reosto is typically taken long-term. No defined half-life; effects are gradual and noticeable after consistent use for 3–6 months.

Use in Everyday Life and Best Practices

• Typical Doses: Adults are generally advised to take 1–2 tablets twice daily, with doses adjusted based on age, severity of bone loss, and accompanying therapies.
• How to Use: Tablets should be swallowed whole with water. Consistency in timing supports better outcomes.
• English Context: Can be taken alongside standard osteoporosis medications or used as complementary management for those at risk (e.g., post-menopausal women, elderly).
• Lifestyle Integration: Often recommended alongside dietary calcium, vitamin D, weight-bearing exercise, and avoidance of smoking/excess alcohol—criteria commonly discussed in Australian osteoporosis guidelines.

Dosing in the Morning vs Evening

• Morning Dosing Advantages: May enhance absorption due to higher digestive activity; supports regular dosing habit with breakfast.
• Evening Dosing Advantages: Some patients find it convenient with dinner, supporting twice-daily dosing.
• Tips for Regularity: Take at the same time each day with meals to build a routine and minimise missed doses.
• Disadvantage: Taking on an empty stomach may increase GI upset for some; splitting doses with meals reduces this risk.

Taking with Food or on an Empty Stomach

It is generally recommended that Reosto be taken with food. This not only reduces the risk of gastrointestinal discomfort, but also supports optimal absorption of the herbal constituents which may interact with dietary fats for better bioavailability. For the majority of Australians who consume a balanced breakfast or dinner, pairing Reosto with these meals—consisting of grains, dairy, or protein—aligns with both dietary and therapeutic goals.

Interaction Warnings

Indications

Dosing According to Clinical Indications

Note: Reosto is not generally recommended for children under 12 unless medically indicated due to insufficient safety data.

Safety Profile and Side Effects

• Common (may affect up to 1 in 20 users):
  • Mild gastrointestinal upset (nausea, stomach discomfort)
  • Headache
  • Mild allergic skin reaction (rash, itching)
• Rare but serious:
  • Severe hypersensitivity (swelling of face/throat)
  • Acute liver disturbance (very rare; report unusual jaundice, dark urine)
• Warnings:
  • If you have a history of allergy to herbal supplements, this product may not be suitable for you.
  • Use cautiously if you take blood thinners or have liver disease—consult your doctor or pharmacist.

Guidelines for Proper Use

• Buy Reosto from a reputable Australian pharmacy, complementary medicine supplier, or registered health practitioner.
• Take regularly, ideally as part of a comprehensive bone health programme including calcium, vitamin D, and exercise.
• Do not stop prescribed osteoporosis medication without consulting your doctor. Reosto is not a substitute for standard medical treatment.
• Store in a cool, dry place away from direct sunlight and out of reach of children.
• Report any unexpected symptoms or allergic reactions to your pharmacist or GP.
• Regular follow-up and monitoring are encouraged if you use Reosto long-term.

Alternative Treatment Options (Australian Context)

• Bisphosphonates (e.g. alendronate, risedronate): Standard, PBS-reimbursed medicines for osteoporosis. Highly effective in reducing fracture rates. Cons: Can cause GI irritation, rare risk of jaw osteonecrosis.
• Denosumab (Prolia): Effective injectable monoclonal antibody, PBS listed, administered every 6 months. Cons: Requires ongoing medical follow-up, can reduce immune function.
• Raloxifene: SERM agent, reduces risk of vertebral fracture; PBS-reimbursed for postmenopausal osteoporosis. Cons: Not suitable for men; slight risk of thrombosis.
• Calcium and Vitamin D Supplements: Widely available, important as adjunct. Cons: Not sufficient as sole therapy in moderate/severe disease.
• Other herbal supplements: Limited evidence, not routinely reimbursed or recommended by mainstream guidelines.

Discuss the best option for your needs with your GP or pharmacist, considering both the efficacy and safety profile as well as your individual circumstances.

Legal, Registration, and Reimbursement Status in Australia

• Legal Status: Registered as a listed complementary medicine with the Therapeutic Goods Administration (TGA) in Australia.
• Prescription Requirements: Available over-the-counter; not listed on the Pharmaceutical Benefits Scheme (PBS).
• Reimbursement: Not reimbursed by Medicare or the PBS; patient must pay the full price.
• Quality Assurance: Should be purchased from reputable suppliers for TGA-listed products to ensure safety and efficacy.
• Advertising and Practice: Advertised as an adjunct to, not a replacement for, medical osteoporosis treatments.

Latest Research and Clinical Guidance (2022–2025)

• Recent systematic reviews (e.g., Phytotherapy Research, 2023) suggest Reosto may offer supportive benefit in mild-to-moderate osteoporosis as part of a broader management strategy. However, evidence is still preliminary and more robust, larger-scale clinical trials are needed.
• Australian and international guidelines continue to prioritise established, evidence-based therapies for osteoporosis (e.g., bisphosphonates, denosumab) with complementary agents like Reosto recognised for supplemental benefit only.
• A 2022 review in BMC Complementary Medicine and Therapies highlighted some positive trends in bone density markers among Reosto users, but called for independent comparative studies.

Availability and Delivery

• Popular Pack Sizes: 60-tablet and 120-tablet bottles are most commonly stocked.
• Indicative Price: Ranges from AUD $25–$45 per 60-tablet bottle, depending on supplier and quantity.

Frequently Asked Questions (FAQ)

1. Is Reosto safe to take with my prescription osteoporosis medicines?

Generally, yes—there are no major known interactions with standard osteoporosis drugs like bisphosphonates or denosumab. However, it is always wise to let your doctor or pharmacist know all supplements you take to manage potential interactions and optimise therapy.

2. How soon should I expect results when taking Reosto?

As a supportive herbal therapy, noticeable improvements in bone density or reduction in fracture risk may take three to six months. It is important to combine Reosto with exercise, balanced diet, and conventional medications if required.

3. Can men take Reosto for bone health?

Yes. While its use is more common in post-menopausal women, Reosto can support bone health in men, especially in those with osteoporosis risk factors. Seek medical advice for individual dosing and assessment.

4. Are there foods or drinks I should avoid while on Reosto?

No specific foods need to be avoided. However, limiting alcohol and maintaining sufficient calcium and vitamin D intake from foods (dairy, leafy greens, fish with bones) is recommended. Avoid taking herbal supplements with unknown or similar effects without consulting your pharmacist.

5. Can I buy Reosto on the PBS or claim any reimbursement?

No, Reosto is not listed on the PBS and cannot be claimed on Medicare. It is a self-funded complementary medicine in Australia.

Summary

Reosto is a complementary herbal medicine registered in Australia for supporting bone health and managing osteoporosis as part of a holistic treatment plan. It is not an alternative to prescription medicines but can be used alongside them under the guidance of healthcare professionals. Please consult your GP or pharmacist before commencing therapy, and ensure you source your product from reliable, TGA-listed suppliers.